183 related articles for article (PubMed ID: 27612427)
21. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
22. The NTP pyrophosphatase DCTPP1 contributes to the homoeostasis and cleansing of the dNTP pool in human cells.
Requena CE; Pérez-Moreno G; Ruiz-Pérez LM; Vidal AE; González-Pacanowska D
Biochem J; 2014 Apr; 459(1):171-80. PubMed ID: 24467396
[TBL] [Abstract][Full Text] [Related]
23. Targeting HCCR expression resensitizes gastric cancer cells to chemotherapy via down-regulating the activation of STAT3.
Zhang JL; Liu XZ; Wang PY; Chen GW; Jiang Y; Qiao SK; Zhu J; Wang X; Pan YS; Liu YC
Sci Rep; 2016 Apr; 6():24196. PubMed ID: 27052330
[TBL] [Abstract][Full Text] [Related]
24. Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer.
Yuan J; Yin Z; Tan L; Zhu W; Tao K; Wang G; Shi W; Gao J
Cancer Lett; 2019 Aug; 457():28-39. PubMed ID: 31078735
[TBL] [Abstract][Full Text] [Related]
25. LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells.
Zhang S; Zheng F; Zhang L; Huang Z; Huang X; Pan Z; Chen S; Xu C; Jiang Y; Gu S; Zhao C; Zhang Q; Shi G
J Exp Clin Cancer Res; 2020 Jul; 39(1):131. PubMed ID: 32653028
[TBL] [Abstract][Full Text] [Related]
26. IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells.
Gao Q; Li XX; Xu YM; Zhang JZ; Rong SD; Qin YQ; Fang J
Cancer Lett; 2020 Apr; 476():67-74. PubMed ID: 32061752
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of KLF17 expression increases the sensitivity of gastric cancer to 5-fluorouracil.
An ZJ; Li Y; Tan BB; Zhao Q; Fan LQ; Zhang ZD; Zhao XF; Li SY
Int J Immunopathol Pharmacol; 2021; 35():20587384211010925. PubMed ID: 33960231
[TBL] [Abstract][Full Text] [Related]
28. LRPPRC contributes to the cisplatin resistance of lung cancer cells by regulating
Hu Y; Cui J; Jin L; Su Y; Zhang X
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649818
[TBL] [Abstract][Full Text] [Related]
29. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
Xu GY; Tang XJ
Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
[TBL] [Abstract][Full Text] [Related]
30. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells.
Imanishi M; Yamamoto Y; Wang X; Sugaya A; Hirose M; Endo S; Natori Y; Yamato K; Hyodo I
Cancer Sci; 2019 Feb; 110(2):639-649. PubMed ID: 30488540
[TBL] [Abstract][Full Text] [Related]
31. DJ-1 overexpression confers the multidrug resistance phenotype to SGC7901 cells by upregulating P-gp and Bcl-2.
Liu HY; Duan GL; Xu RY; Li XR; Xiao L; Zhao L; Ma ZX; Xu XW; Qiu LJ; Zhu ZM; Chen HP
Biochem Biophys Res Commun; 2019 Oct; 519(1):73-80. PubMed ID: 31477270
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma.
Wang J; Liu W; Zhao Q; Qi Q; Lu N; Yang Y; Nei FF; Rong JJ; You QD; Guo QL
Toxicology; 2009 Feb; 256(1-2):135-40. PubMed ID: 19084572
[TBL] [Abstract][Full Text] [Related]
33. Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer.
Hu H; Wang M; Guan X; Yuan Z; Liu Z; Zou C; Wang G; Gao X; Wang X
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29371412
[TBL] [Abstract][Full Text] [Related]
34. Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.
Yu C; Chen DQ; Liu HX; Li WB; Lu JW; Feng JF
Biomed Pharmacother; 2019 Jan; 109():2327-2334. PubMed ID: 30551491
[TBL] [Abstract][Full Text] [Related]
35. The nucleotidohydrolases DCTPP1 and dUTPase are involved in the cellular response to decitabine.
Requena CE; Pérez-Moreno G; Horváth A; Vértessy BG; Ruiz-Pérez LM; González-Pacanowska D; Vidal AE
Biochem J; 2016 Sep; 473(17):2635-43. PubMed ID: 27325794
[TBL] [Abstract][Full Text] [Related]
36. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
37. HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway.
Han Y; Song C; Wang J; Tang H; Peng Z; Lu S
Mol Carcinog; 2018 Jun; 57(6):722-734. PubMed ID: 29436749
[TBL] [Abstract][Full Text] [Related]
38. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway.
Xiao F; Ouyang B; Zou J; Yang Y; Yi L; Yan H
Drug Dev Res; 2020 Aug; 81(5):544-550. PubMed ID: 32096264
[TBL] [Abstract][Full Text] [Related]
39. Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells.
Liu Y; Bi T; Dai W; Wang G; Qian L; Shen G; Gao Q
Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):477-84. PubMed ID: 26892272
[TBL] [Abstract][Full Text] [Related]
40. MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer.
Wang C; Wen Z; Xie J; Zhao Y; Zhao L; Zhang S; Liu Y; Xue Y; Shi M
Biochem Biophys Res Commun; 2017 Apr; 485(3):665-671. PubMed ID: 28235486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
